← FDA Drug Approvals (Drugs@FDA)

VIVITROL

NDA · New Drug Application · Sponsor: ALKERMES · Approved 2006-04-13

Drug application

FDA Application #

NDA021897

Application type

New Drug Application

Brand name

VIVITROL

Generic name

NALTREXONE

Active ingredients

NALTREXONE

Dosage form

FOR SUSPENSION, EXTENDED RELEASE

Route

INTRAMUSCULAR

Marketing status

Prescription

Sponsor

ALKERMES

Manufacturer

Alkermes, Inc.

First approval

2006-04-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown